Mental Health Nurse jobs in United Kingdom

The post is based in the Imperial College Infection Service primarily between Charing Cross Hospital (Medical Mycology Laboratory) and Hammersmith (Immunocompromised patient groups). The Trust Fellowship is 90% Research and 10% Clinical and will enable exposure to all aspects of fungal disease clinically and from a research perspective. The primary aim of the post will be to deliver a clinical analytic electronic healthcare record data platform to enable systematic delivery of antifungal stewardship data capture, analytics, patient identification and digital health interventions. It will represent an outstanding opportunity for sub-specialist training in invasive fungal disease clinical management, antifungal stewardship, digital health interventions and clinical analytics approaches.

The Fellow will seek to both undertake a retrospective 3 year analysis to identify all patients with invasive fungal disease at Imperial College Healthcare during the COVID era, as well as development of a real-world prospective analysis that will link to an antifungal dashboard. This will allow is to generate real-time data on patients with invasive fungal disease to enable systematic antifungal stewardship.

The program will be supported by the core multidisciplinary antifungal stewardship team (Meg Coleman Respiratory, and Darius Armstrong-James Medical Mycology, Mark Gilchrist and Richard Wilson Pharmacy).

The Fellow will divide their time between research 90% and clinical duties 10%, which will be primarily supporting the Fungal MDT and antifungal stewardship program. There will be a degree of flexibility to accommodate the successful candidate’s preferences and interest. However the primary aim will be to develop electronic health systems for antifungal stewardship and undertake data analysis focussed on prescribing, diagnostics and outcomes in our populations with fungal disease.

At Imperial College Healthcare you can achieve extraordinary things with extraordinary people, working with leading clinicians pushing boundaries in patient care. Become part of a vibrant team living our values - expert, kind, collaborative and aspirational. You’ll get an experience like no other and will fast forward your career.Benefits include career development, flexible working and wellbeing, staff recognition scheme. Make use of optional benefits including Cycle to Work, car lease schemes, season ticket loan or membership options for onsite leisure facilities.

We are committed to equal opportunities and improving the working lives of our staff and will consider applications to work flexibly, part time or job share. Please talk to us at interview.

The post is funded by a recent industrial sponsorship to enable fungal disease stewardship, funded by Gilead Sciences. The key job descriptors are as follows:

1 To provide outstanding training for an infection or respiratory clinical trainee to digital methods in antifungal

stewardship, and medical mycology.

2 To develop the necessary data informatics pipelines and analytical approaches required to undertake retrospective and prospective analysis of the incidence, treatment and outcome from invasive fungal disease at Imperial College Healthcare.

3 To undertake a 3 year retrospective analysis of the incidence and outcome from invasive fungal disease at Imperial College Healthcare, with a focus on emerging groups of risk patients, such as those receiving novel

immunomodulators and those patients in critical care.

4 To characterise the impact of viral pneumonia on critical care invasive fungal disease and antifungal usage and

expenditure

5 To undertake a prospective analysis of invasive fungal disease incidence and outcomes at Imperial College

Healthcare

6 To develop an antifungal stewardship dashboard to enable real-time visualisation of integrated clinical and prescribing data on all patients with a diagnosis of invasive fungal disease and those patients receiving antifungal therapy.

7 To public disseminate the outputs of the Fellowship through presentation of data at national and international

conferences as well as through the preparation of high-quality original research manuscripts.








This advert closes on Wednesday 30 Jul 2025